Response of Jinjia Shares: Mint-flavored E-cigarettes Mainly Sold to Europe

Business by 2FIRSTS.ai
Jul.01.2024
Response of Jinjia Shares: Mint-flavored E-cigarettes Mainly Sold to Europe
Investors questioned Jinjia Corporation about menthol-flavored e-cigarette products, to which the company stated compliance with regulations for overseas sales.

Recently, an investor asked a question on the investor interaction platform "Interactive Easy" to Jing Jia Stock (002191.SZ): Which subsidiary of the company, Yunnan Changyi or Yunnan Yunshuo, produces products related to Mint Choon?

 

In response, Jinjia Group stated that in accordance with the "Regulations on the Management of E-cigarettes", the sale of flavored e-cigarettes other than tobacco flavor is prohibited domestically. The company's affiliated company, Yunnan Sparking Science and Technology, provides menthol flavoring products to other qualified e-cigarette production enterprises for e-cigarette production, and exports them in finished form overseas, strictly complying with relevant regulations.

 

Investors also asked whether the company's overseas factories produce and sell menthol-flavored e-cigarettes. They inquired about whether the disposable and pod system products also come in menthol flavor, and if these products are being marketed in Europe and the United States. They also wanted to know if the overseas-produced Lono Way Yuet brand e-cigarettes have a mint flavor and which regions they are sold in.

 

Jinjia Group responded that their new tobacco overseas production companies currently provide customers with products such as mint-flavored e-cigarettes that comply with the standards and regulations of the customers' respective countries or regions, primarily sold to European countries.

 

Finally, regarding the positive impact on overseas production and sales of Jinjia brought by the approval of four menthol-flavored e-cigarette by the US FDA last week, Jinjia Group stated that the company is closely monitoring the latest developments in regulations and standards in various countries regarding e-cigarettes. They will strengthen research and development of product diversity and market expansion, and strive to improve sales performance overseas in compliance with local regulations and market access requirements.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

The Consumers Association of Penang of Malaysia: Should Follow Singapore's Lead in Treating E-Cigarettes as Drugs for Comprehensive Regulation
The Consumers Association of Penang of Malaysia: Should Follow Singapore's Lead in Treating E-Cigarettes as Drugs for Comprehensive Regulation
Consumer Association of Penang (CAP) urges Malaysian government to follow Singapore in treating e-cigarettes as a drug threat.
Aug.25 by 2FIRSTS.ai
Product | Clear Tank + 40,000 Puffs: EBCREATE BC PRO 40K Launches in the U.S.
Product | Clear Tank + 40,000 Puffs: EBCREATE BC PRO 40K Launches in the U.S.
EBCREATE BC PRO 40K disposable e-cigarette with Clear Tank design hits US market at $24.99.
Aug.13 by 2FIRSTS.ai
Gold Standard for Natural Nicotine Regulation? — Heno Bio Explains What Nicotine Companies Can Learn from JUUL's PMTA
Gold Standard for Natural Nicotine Regulation? — Heno Bio Explains What Nicotine Companies Can Learn from JUUL's PMTA
In July 2025, JUUL received FDA PMTA approval, marking a new era of higher scientific standards in the vaping industry. Using high-purity natural nicotine and submitting detailed toxicology and stability data, JUUL set a new benchmark for regulatory compliance. 2Firsts invited leading natural nicotine manufacturer Heno Bio to analyze JUUL’s success and highlight the importance of science-based evaluation and regulatory foundations.
Aug.04
2Firsts Interview | Adding Evidence: How Two Recent Blu Studies Strengthen the Case for NGPs As THR Tools
2Firsts Interview | Adding Evidence: How Two Recent Blu Studies Strengthen the Case for NGPs As THR Tools
2Firsts interviewed Elizabeth Clarke, scientific lead at Imperial Brands, on the latest blu behavioral studies. Results showed that smokers with no intention to quit reduced cigarette use by nearly 29% in one week, and about one-third to 40% had significantly reduced or quit at six months. Clarke highlighted the role of flavor diversity and behavioral science, urging science-based harm reduction policies to demonstrate blu’s public health potential.
Jul.17
2Firsts Observation: Global Travel Retail Becomes the Main Battleground for NGP as PMI and BAT Step Up Competition
2Firsts Observation: Global Travel Retail Becomes the Main Battleground for NGP as PMI and BAT Step Up Competition
Recently, international tobacco companies have accelerated their expansion into the global travel retail market. British American Tobacco (BAT) introduced the Vuse Ultra for the first time at Frankfurt Airport, while Philip Morris International (PMI) launched a travel information platform for smoke-free products. 2Firsts observes that the high-value passenger traffic at airports, combined with the regulatory advantages of travel retail, has made it an important arena for NGP brand expansion.
Aug.15 by 2FIRSTS.ai
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai